
Free Daily Podcast Summary
by The Lead Podcast presented by Heart Rhythm Society
The Lead – a weekly journal review podcast that is designed to keep you up to date and informed on the latest publications and hottest topics in electrophysiology. Key takeaways, in-depth interpretations, and informative interviews are all fitted into 15 minute time slots, so that they fit easily into your busy schedule.
The most recent episodes — sign up to get AI-powered summaries of each one.
Description: In this episode of The Lead, recorded live at HRX 2026, host Michael S. Lloyd, MD, FHRS, of Emory University, is joined by Dominik K. Linz, MD, PhD, of Maastricht University Medical Center, and Ashish A. Bhimani, BSE, MD, FHRS, of Piedmont Heart Institute, to discuss the article "Safety and performance of a novel ICD lead for left bundle branch area pacing: Results from the ASCEND CSP trial," published in Heart Rhythm. The panel examines the study's findings on implantation success, pacing and sensing performance, defibrillation effectiveness, and procedural safety, while exploring concerns about long-term lead durability, tricuspid valve interactions, and the potential role of conduction system pacing in patients requiring defibrillator therapy. Learning Objectives: Describe the design, patient population, and primary safety and effectiveness outcomes of the ASCEND CSP trial evaluating a novel ICD lead for left bundle branch area pacing. Evaluate the performance of the novel ICD lead, including implantation success, conduction system capture, pacing and sensing thresholds, defibrillation testing, and procedure-related complications. Assess the potential clinical applications and long-term limitations of combining conduction system pacing and defibrillation capabilities in a single lead, including concerns related to tricuspid valve function, lead extraction, and durability. Podcast Contributors Host: Michael S. Lloyd, MD, FHRS | Emory University Guests: Dominik K Linz, MD, PhD | Maastricht University Medical Center Ashish A. Bhimani, BSE, MD, FHRS | Piedmont Heart Institute Faculty Disclosures All relevant financial relationships have been mitigated. Host and Contributor Disclosure(s): M. Lloyd Honoraria/Speaking/Consulting Fee: Medtronic Membership on Advisory Committee: Boston Scientific, ABIM D. Linz Nothing to disclose A. Bhimani Honoraria/Speaking/Consulting Fee: Boston Scientific, Biotronik, St. Jude Medical, Medtronic, Pacemate Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose. M. Baldwin: No relevant financial relationships with ineligible companies to disclose.</s
Description: In this episode of The Lead, recorded live at HRX 2026, host Jason T. Jacobson, MD, FHRS, of Westchester Medical Center–New York Medical College, is joined by Jason G. Andrade, MD, FHRS, of Vancouver General Hospital, and Jason D. Roberts, MD, of McMaster University, to discuss the recently published JAMA article "Pulmonary Vein Isolation Using Pulsed Field Ablation With vs Without Posterior Wall Isolation in Patients With Symptomatic Persistent Atrial Fibrillation: The PIFPAF Randomized Clinical Trial." The panel examines the trial's findings, including the lack of a statistically significant reduction in its primary endpoint, potential benefits in reducing atrial fibrillation burden and longer-duration recurrences, and the implications of trial design, outcome definitions, and patient selection for clinical practice. Learning Objectives: Describe the design, patient population, and primary and secondary outcomes of the PIFPAF trial comparing pulmonary vein isolation alone with additional posterior wall isolation using pulsed field ablation in patients with persistent atrial fibrillation. Evaluate the clinical significance of atrial fibrillation recurrence duration and burden as measures of ablation success, including the limitations of a 30-second recurrence threshold. Assess the potential benefits and limitations of posterior wall isolation using pulsed field ablation and its implications for selecting appropriate patients with persistent atrial fibrillation. Podcast Contributors Host: Jason T. Jacobson, MD, FHRS | Westchester Med Center-New York Medical College Guests: Jason G. Andrade, MD, FHRS | Vancouver General Hospital Jason D. Roberts, MD | McMaster University Faculty Disclosures J. Jacobson Honoraria/Speaking/Consulting Fee: Zoll Medical Corporation, Vektor Medical, Inc., CardioFocus, Inc., Abbott Medical, Johnson and Johnson Stock Options-Privately Held: Atlas 5D J. Andrade Nothing to disclose J. Roberts Intellectual Property Rights: Venca Research Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose. M. Baldwin: No relevant financial relationships with ineligible companies to disclose.
Description: In this episode of The Lead, recorded live at HRX 2026, host Deep Chandh Raja, MBBS, MD, PhD, FHRS, of Australian National University and Kauvery Hospital, is joined by Niraj Sharma, MD, FHRS, of Northside Hospital, and Deepak Padmanabhan, MD, FHRS, of Narayana Institute of Cardiac Sciences in Bengaluru, to discuss the article "One-Year Outcomes of the MODULAR ATP Trial: A Novel Leadless Pacemaker in Wireless Communication With a Subcutaneous Implantable Cardioverter Defibrillator," published in Circulation: Arrhythmia and Electrophysiology. The panel examines the effectiveness and limitations of this modular system, including antitachycardia pacing outcomes, inappropriate shocks, wireless communication failures, and the need for comparative studies to establish its clinical benefits. Learning Objectives: Describe the design, patient population, and one-year outcomes of the MODULAR ATP trial evaluating a wirelessly communicating subcutaneous ICD and leadless pacemaker system. Evaluate the effectiveness and limitations of antitachycardia pacing delivered through the modular system, including ventricular tachycardia termination, arrhythmia acceleration, inappropriate shocks, and communication failures. Assess the clinical implications of the trial findings and identify areas requiring further investigation before broader adoption of modular cardiac rhythm management systems. Podcast Contributors Host: Deep Chandh Raja, MBBS, MD, PhD, FHRS | Australian National University, Kauvery Hospital Guests: Niraj Sharma, MD, FHRS | Northside Hospital Deepak Padmanabhan, MD, FHRS | Narayana Institute of Cardiac Sciences, Bengaluru Host and Contributor Disclosure(s):</span
Description: In this episode of The Lead, recorded live at HRX 2026, host Melissa E. Middeldorp, MPH, PhD, FHRS, is joined by James Freeman, MD, MPH, MSci, and Rachel Schreier, MSN, ACNP, APRN, to discuss the recently published New England Journal of Medicine article "Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk." The panel examines the findings of the SINGLE-AF trial, including the potential benefits of direct oral anticoagulants (DOACs) in patients with intermediate stroke risk, the study's low event rates and limitations, and the implications for individualized risk assessment, shared decision-making, and clinical practice. Learning Objectives: Describe the design, patient population, and primary findings of the SINGLE-AF trial evaluating DOAC therapy in patients with atrial fibrillation and intermediate stroke risk. Evaluate the limitations of the SINGLE-AF trial, including low event rates, patient demographics, antiplatelet use, and the potential influence of atrial fibrillation burden and prior ablation. Apply the trial findings to individualized anticoagulation decisions by considering stroke risk factors, bleeding risk, patient preferences, and shared decision-making. Host: Melissa E. Middeldorp, MPH, PhD, FHRS Guests: James Freeman, MD, MPH, MSci and Rachel Schreier, MSN, ACNP, APRN Disclosures: M. Middeldorp Nothing to disclose J. Freeman Honoraria/Speaking/Consulting Fees: Boston Scientific, Biosense Webster, Inc. Membership on Advisory Committee: Medtronic, Pacemate Research (Contracted Grants): American College of Cardiology, National Institutes for Health R. Schreier Nothing to disclose Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose. M. Baldwin: No relevant financial relationships with ineligible companies to disclose.
Description: In this episode of The Lead, recorded live at HRX 2026, host Jason T. Jacobson, MD, FHRS, is joined by Michael S. Lloyd, MD, FHRS, and Igor R. Efimov, PhD, FHRS, to discuss the article "The Forgotten History of Semi-Implanted Radiofrequency and Inductively Powered Cardiac Pacing Systems," published in Pacing and Clinical Electrophysiology (PACE). The panel explores the evolution of early cardiac pacing technologies, the challenges associated with externally powered systems, and how historical innovations in wireless energy transfer may inform future developments in pacemaker design, miniaturization, and alternative power sources. Learning Objectives: Describe the historical development of semi-implanted radiofrequency- and inductively powered cardiac pacing systems and their role in the evolution of pacemaker technology. Compare the technical advantages and limitations of early externally powered pacing systems with fully implanted, battery-powered pacemakers. Evaluate the potential applications of wireless energy transfer and alternative power sources in future cardiac pacing technologies. Host: Jason T. Jacobson, MD, FHRS | Westchester Med Center-New York Med Coll Guests: Michael S. Lloyd, MD, FHRS | Emory University Igor R. Efimov, PhD, FHRS | Northwestern University Faculty Disclosures: J. Jacobson Honoraria/Speaking/Consulting Fee: Zoll Medical Corporation, Vektor Medical, Inc., CardioFocus, Inc., Abbott Medical, Johnson and Johnson Stock Options-Privately Held: Atlas 5D M. Lloyd Honoraria/Speaking/Consulting Fee: Medtronic Membership on Advisory Committee: Boston Scientific, ABIM I. Efimov Nothing to disclose Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose. M. Baldwin: No relevant financial relationships with ineligible companies to disclose.
Description: In this episode of The Lead, host Lisa Roelle, PAC, Washington University in St. Louis, is joined by M. Cecilia Gonzalez Corcia, MD, MDCM, PhD, CEPS-P, Sainte-Justine, and John K. Triedman, MD, FHRS, Children's Hospital Boston, Cardiology, to discuss "Artificial Intelligence-Enhanced Implantable Loop Recorders in Pediatric Patients: Effects on Device Performance and Clinical Workflow in a Single-Center Experience." The panel examines the potential for AI-based filtering to reduce nonactionable alerts and clinical workload associated with remote monitoring while considering pediatric-specific physiology, the limitations of extrapolating from adult data, and the need to preserve diagnostic sensitivity and clinical judgment when incorporating these technologies into pediatric electrophysiology practice. Learning Objectives: Describe the effects of AI-based filtering on nonactionable alerts and clinical workflow in pediatric patients with implantable loop recorders. Evaluate pediatric-specific physiologic and clinical factors that may influence the performance of AI-based arrhythmia detection algorithms. Assess the benefits and limitations of incorporating AI-enhanced remote monitoring into pediatric electrophysiology practice while maintaining diagnostic sensitivity and appropriate clinical oversight. Host: Lisa Roelle, PA-C Guests: John K. Triedman, MD, FHRS and M. Cecilia Gonzalez Corcia, MD, MDCM, PhD, CEPS-P Faculty Disclosures: All relevant financial relationships have been mitigated. Host and Contributor Disclosure(s): L. Roelle Nothing to disclose J. Triedman Honoraria/Speaking/Consulting Fees: Biosense Webster, Inc. Royalty Income: UpToDate, Inc. M. C. Gonzalez Corcia Nothing to disclose
In this episode of The Lead, host Melissa E. Middeldorp, MPH, PhD, FHRS, is joined by David J. Slotwiner, MD, FHRS, and Alessandra Pina, MBBS, MD, to discuss "Integrated Care Management and Comprehensive Geriatric Assessment Using an mHealth-Based Approach in Older Multimorbid Patients With Atrial Fibrillation: The AFFIRMO Cluster Randomised Trial." The panel examines the trial's evaluation of an mHealth-based integrated care approach for older patients with atrial fibrillation and comorbidities, exploring its neutral effect on hospitalization, challenges with patient engagement, characteristics of the study population, and implications for developing and implementing digital health interventions. Learning Objectives: Describe the design, patient population, integrated care intervention, and clinical outcomes of the AFFIRMO cluster randomized trial. Evaluate factors that may have contributed to the trial's neutral primary outcome, including characteristics of the study population, baseline management of atrial fibrillation, and patient engagement with the mHealth intervention. Assess the opportunities and challenges associated with using mHealth tools to support integrated atrial fibrillation and comorbidity management in older adults. Podcast Contributors Host: Melissa E. Middeldorp, MPH, PhD, FHRS Guests: David J. Slotwiner, MD, FHRS and Alessandra Pina, MBBS, MD All relevant financial relationships have been mitigated. Host and Contributor Disclosure(s): <br /
Description: In this episode of The Lead, host Jason T. Jacobson, MD, FHRS, is joined by Sei Iwai, MD, FHRS, and Jeanne E. Poole, MD, FHRS, CCDS, to discuss "Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: The CMR GUIDE Randomized Clinical Trial." The panel examines the trial's findings on using cardiovascular magnetic resonance–identified myocardial scar to guide primary prevention ICD implantation, including limitations of the study and current approaches to sudden cardiac death risk stratification, as well as the potential role of more sophisticated, dynamic risk-prediction models. Learning Objectives: Describe the design, patient population, primary outcome, and key findings of the CMR GUIDE randomized clinical trial. Evaluate the limitations of using cardiovascular magnetic resonance–identified myocardial scar to guide primary prevention ICD implantation in patients with an LVEF of 36% to 50%. Assess current challenges and emerging approaches to sudden cardiac death risk stratification, including the potential use of multimodal and dynamic risk-prediction models. Host: Jason T. Jacobson, MD, FHRS Guests: Sei Iwai, MD, FHRS and Jeanne E. Poole, MD, FHRS, CCDS Faculty Disclosures: J. Jacobson Honoraria/Speaking/Consulting Fee: Zoll Medical Corporation, Vektor Medical, Inc., CardioFocus, Inc., Abbott Medical, Johnson and Johnson Stock Options-Privately Held: Atlas 5D S. Iwai Honoraria/Speaking/Consulting Fee: Alta Thera Pharmaceuticals, Biotronik, Johnson and Johnson, CardioFocus, Inc. J. Poole Honoraria/Speaking/Consulting Fee: Heart Rhythm Society Research (Contracted Grants): Boston Scientific, AtriCure, Inc., Kestra, Inc., Biotronik
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

Core IM | Internal Medicine Podcast
A podcast exploring internal medicine through clinical reasoning, management decisions, and practical teaching points.

The Internet Book of Critical Care Podcast
A podcast exploring critical care medicine through chapter discussions and evidence-based updates from The Internet Book of Critical Care.

ICU Ed and Todd-Cast
Eddie and Todd

Heart Led Wellness
Teaches women to heal their relationship with food through nervous system regulation and somatic practices.

Frankly Speaking About Family Medicine
Discusses current topics and developments in primary care and family medicine.

The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.

The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.

ADHD Experts Podcast
ADHD specialists answer questions from adults and parents about managing attention deficit in school, work, and family life.

Red Pill Your Healthcast
Two healthcare providers discuss overlooked health issues and empower listeners to make informed decisions for their families.

Invictus Reviews
Emergency medicine board exam prep with Mel Herbert and team, covering core topics for all levels.

The Pulse
Explores surprising stories in health and science, from operating rooms and labs to breakthrough innovations.

Health vs Hype with the American Medical Association
A medical expert debunks viral health trends and misinformation with science-backed insights from physicians.
The Lead – a weekly journal review podcast that is designed to keep you up to date and informed on the latest publications and hottest topics in electrophysiology. Key takeaways, in-depth interpretations, and informative interviews are all fitted into 15 minute time slots, so that they fit easily into your busy schedule.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from The Lead Podcast presented by Heart Rhythm Society in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of The Lead Podcast presented by Heart Rhythm Society as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by The Lead Podcast presented by Heart Rhythm Society.
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
The Lead Podcast presented by Heart Rhythm Society publishes weekly. Our AI generates a summary within hours of each new episode.
The Lead Podcast presented by Heart Rhythm Society covers topics including Education, Courses. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.